Stock listing
Kailera Therapeutics, Inc.
Selected listing: KLRA · NASDAQ · USD · US
Kailera Therapeutics, Inc. (NASDAQ:KLRA), Health Technology. Latest release Oct 1, 2026: Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual…
- Ticker
- NASDAQ:KLRA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Kailera Therapeutics, Inc.
The company focuses on developing innovative therapies to address unmet medical needs. Kailera is committed to advancing its research and development efforts to improve patient outcomes.
Latest news from Kailera Therapeutics, Inc.
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
September 30, 2026
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
October 1, 2026
Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
September 30, 2026
Kailera Therapeutics to Participate in September Investor Conferences
September 16, 2026
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
Research Kailera Therapeutics, Inc.
Kailera Therapeutics, Inc. company profile
View the public company page for Kailera Therapeutics, Inc. on 6ix.
Kailera Therapeutics, Inc. news
Read company news and market updates connected to Kailera Therapeutics, Inc..
Kailera Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kailera Therapeutics, Inc..